Home Gene Therapy New Gene Targeting Drug Shows Promise In Child Brain Tumors

New Gene Targeting Drug Shows Promise In Child Brain Tumors

84
0

St. Jude Research Hospital’s Giles Robinson has led a trial conducting research on a drug called entrectinib (Roche). The gene therapy shows promise in some of the most difficult pediatric tumors. The drug only targets a small subset of child cancers; however, patients whose tumors harbor the mutations targeted by the dug and have responded to treatment. Follow the link to Bloomberg to learn more about this Roche gene therapy study.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.